Improved survival among colon cancer patients with increased differentially expressed pathways
暂无分享,去创建一个
[1] Robert Tibshirani,et al. Finding consistent patterns: A nonparametric approach for identifying differential expression in RNA-Seq data , 2013, Statistical methods in medical research.
[2] Sabine Tejpar,et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer , 2013, The Journal of pathology.
[3] D. Burgess. Gene expression: Colorectal cancer classifications , 2013, Nature Reviews Cancer.
[4] Cesare Furlanello,et al. Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review , 2012, PloS one.
[5] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[6] Kurt Hornik,et al. The Comprehensive R Archive Network , 2012 .
[7] R. Wolff,et al. A Comparison of Colon and Rectal Somatic DNA Alterations , 2009, Diseases of the colon and rectum.
[8] A. Astolfi,et al. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. , 2009, Cancer treatment reviews.
[9] M. Sułkowska,et al. Relations of TGF‐beta1 with HIF‐1alpha, GLUT‐1 and longer survival of colorectal cancer patients , 2009, Pathology.
[10] Robert Tibshirani,et al. Gene Expression Profiling Predicts Survival in Conventional Renal Cell Carcinoma , 2005, PLoS medicine.
[11] R. Wolff,et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. , 2005, Gastroenterology.
[12] A. Sánchez-Capelo. Dual role for TGF-β1 in apoptosis , 2005 .
[13] T. Ørntoft,et al. Gene expression in colorectal cancer. , 2002, Cancer research.
[14] M. Leppert,et al. Prognostic significance of p53 mutations in colon cancer at the population level , 2002, International journal of cancer.
[15] M. Leppert,et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Leppert,et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. , 2000, Journal of the National Cancer Institute.
[18] K. Anderson,et al. Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. , 2000, Mutation research.
[19] J. Potter,et al. Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA) , 1999, Cancer Causes & Control.
[20] Chi V. Dang,et al. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.
[21] J. Potter,et al. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States , 1997, Cancer Causes & Control.
[22] D. Smith,et al. Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] A. Sánchez-Capelo. Dual role for TGF-beta1 in apoptosis. , 2005, Cytokine & growth factor reviews.
[24] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .